Luteolin Isolated from Cuscuta Chinensis Lam Inhibits Lung Cancer Cell Viability and Migration via Co-Treatment with Mithramycin A

Luteolin may suppresses the viability, invasion, migration, and adhesion of lung cancer cells via co-treatment with mithramycin A.

Authors

Institutions

Publication Details

Journal
Current Cancer Drug Targets
Published
2026-01-08
DOI
https://doi.org/10.2174/0115680096433191251202075137
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Luteolin Isolated from Cuscuta Chinensis Lam Inhibits Lung Cancer Cell Viability and Migration via Co-Treatment with Mithramycin A

Taierpuke Maimaiti, Mourboul Ablise
Current Cancer Drug Targets
Flavonoids in Medical Research
article

Luteolin Isolated from Cuscuta Chinensis Lam Inhibits Lung Cancer Cell Viability and Migration via Co-Treatment with Mithramycin A

Taierpuke Maimaiti, Mourboul Ablise
article en

Abstract

Luteolin may suppresses the viability, invasion, migration, and adhesion of lung cancer cells via co-treatment with mithramycin A.

Current Cancer Drug TargetsVol. 26
Xinjiang Medical University (CN), Xinjiang University (CN)
Openalex Percentile: Top 84%
Flavonoids in Medical Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Luteolin Isolated from Cuscuta Chinensis Lam Inhibits Lung Cancer Cell Viability and Migration via Co-Treatment with Mithramycin A — Taierpuke Maimaiti, Mourboul Ablise · Current Cancer Drug Targets (2026) | TGRS Research Map | TGRS